Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2017.12.21
发行股份购买资产暨关联交易报告书（修订稿）
2017.12.21
关于中国证监会并购重组审核委员会审核公司重大资产重组事项停牌的公告
2017.12.21
中天国富证券有限公司关于公司发行股份购买资产暨关联交易行政许可项目审查一次反馈意...
2017.12.21
中天国富证券有限公司关于深圳市多普乐实业发展有限公司业绩真实性的专项核查报告（修订...
2017.12.21
关于公司发行股份购买资产申请的反馈意见的回复
2017.12.21
北京市中伦律师事务所关于公司发行股份购买资产暨关联交易的补充法律意见书（四）
2017.12.13
关于深圳市多普乐实业发展有限公司报告期业绩真实性之专项核查报告
2017.12.13
沃克森（北京）国际资产评估有限公司关于中国证监会对关于公司发行股份购买资产申请的反...
2017.12.13
备考审阅报告（更新后）
2017.12.13
深圳市多普乐实业发展有限公司审计报告（更新后）
第一页
上一页
68
69
70
71
72
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
